What are future directions in RTK-targeted Cancer therapy?
Future directions in RTK-targeted cancer therapy include the development of next-generation inhibitors that overcome resistance, combination therapies that target multiple signaling pathways, and personalized medicine approaches that tailor treatment to the genetic profile of individual tumors. Additionally, ongoing research aims to better understand the biology of RTKs and their role in cancer to identify new therapeutic targets.